To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Federal Drug Control Programs, High Intensity Drug Trafficking Areas Program for fiscal year 2024.
Impact
If enacted, HB 2072 would significantly influence the operational capacity of federal drug control initiatives. By limiting funds available for programs like the High Intensity Drug Trafficking Areas (HIDTA) Program, the bill could impact federal efforts to combat drug trafficking at state and local levels. This move has been described as a reallocation of focus, pushing for a stricter examination of how drug policy funds are utilized and which programs yield the best results. The implications here could also influence state laws that align with federal drug policies, especially in areas heavily affected by drug-related issues.
Summary
House Bill 2072 seeks to impose limitations on the availability of funding for various federal drug control programs, including the Executive Office of the President and the Office of National Drug Control Policy for the fiscal year 2024. The bill specifically targets the appropriations allocated for initiatives that focus on combating drug addiction and trafficking in the United States. Supporters of the bill argue that it is necessary to ensure a more efficient allocation of federal resources by prioritizing funding based on effectiveness and outcomes of existing programs.
Contention
There are notable divisions among lawmakers regarding the potential consequences of HB 2072. Critics, including certain advocacy groups and legislators, argue that reducing funding for federal drug control programs may undermine ongoing efforts to address the critical drug crisis in the U.S. They express concerns that limiting resources could lead to a resurgence of drug-related issues and weaken support systems in communities facing high drug-related challenges. Proponents of the bill contend that existing programs need to demonstrate tangible results before receiving continued funding, framing the discussion around accountability and efficacy in public spending.
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Other Federal Drug Control Programs for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Office of National Drug Control Policy, Salaries and Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Official Residence of the Vice President, Operating Expenses for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, National Security Council and Homeland Security Council for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Executive Residence at the White House, White House Repair and Restoration for fiscal year 2024.
To provide for a limitation on availability of funds for Executive Office of the President, Executive Residence at the White House, Operating Expenses for fiscal year 2024.